Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

NewAmsterdam Pharma (NAMS) Assets Average (2024 - 2025)

Historic Assets Average for NewAmsterdam Pharma (NAMS) over the last 2 years, with Q3 2025 value amounting to $800.8 million.

  • NewAmsterdam Pharma's Assets Average rose 8078.49% to $800.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $800.8 million, marking a year-over-year increase of 8078.49%. This contributed to the annual value of $605.9 million for FY2024, which is 4676.91% up from last year.
  • NewAmsterdam Pharma's Assets Average amounted to $800.8 million in Q3 2025, which was up 8078.49% from $816.8 million recorded in Q2 2025.
  • NewAmsterdam Pharma's Assets Average's 5-year high stood at $841.5 million during Q1 2025, with a 5-year trough of $417.8 million in Q1 2024.